Chinese Patent Drug Manufacturing in China - IBISWorld Industry Market Research

Chinese Patent Drug Manufacturing in China

Chinese Patent Drug Manufacturing in China - IBISWorld Industry Market Research
Chinese Patent Drug Manufacturing in China
Published Feb 11, 2015
37 pages — Published Feb 11, 2015
Price US$ 660.00  |  Buy this Report Now

About This Report


Skepticism about the effectiveness of Western medicine in China has led to the rising popularity of Chinese patent medicine, which is considered to be less toxic and have fewer side effects. Increasingly, patients are choosing traditional Chinese medicine as their primary treatment. As a result, demand for traditional Chinese patent medicine has been growing rapidly.

Over the five years through 2015, revenue for the Chinese Patent Drug Manufacturing industry has been growing at an annualized rate of 22.6% to an estimated $121.9 billion.

The Chinese Patent Drug Manufacturing industry in China processes Chinese herbs to produce traditional Chinese patent medicine in capsule, powder, and liquid forms. Chinese traditional medicine pills are not manufactured by this industry (see IBISWorld industry report 2730).

The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.

Document ID
Report Type
PDF Adobe Acrobat
Buy Now

IBISWorld Industry Market Research—IBISWorld is a leading strategic business information provider that offers comprehensive information on more than 700 US industries covering 4,000 individual product segments. They also provide global industry and industry risk rating reports covering Australia, the United Kingdom and China. IBISWorld data offers detailed analysis on growth trends, the competitive environment and key issues. Reports average 30 to 40 pages and contain figures; market characteristics; product, market and service segmentation; industry conditions, current and historical performance analysis; risk scores; industry participants and market share; factors to success; and 5-year forecasts with forecast analysis.

About the Author

Cite this Report

IBISWorld Industry Market Research. "Chinese Patent Drug Manufacturing in China" Feb 11, 2015. Alacra Store. Apr 20, 2018. <>
IBISWorld Industry Market Research. (2015). Chinese Patent Drug Manufacturing in China Feb 11, 2015. New York, NY: Alacra Store. Retrieved Apr 20, 2018 from <>
US$ 660.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.